New dawn of cannabinoid pharmacology
- PMID: 8165721
- DOI: 10.1016/0165-6147(94)90106-6
New dawn of cannabinoid pharmacology
Similar articles
-
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.Mol Pharmacol. 1993 Sep;44(3):498-503. Mol Pharmacol. 1993. PMID: 8371711
-
Effects of anandamide on cannabinoid receptors in rat brain membranes.Biochem Pharmacol. 1994 Feb 11;47(4):711-5. doi: 10.1016/0006-2952(94)90134-1. Biochem Pharmacol. 1994. PMID: 8129747
-
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.Br J Pharmacol. 1993 Dec;110(4):1483-90. doi: 10.1111/j.1476-5381.1993.tb13989.x. Br J Pharmacol. 1993. PMID: 8306090 Free PMC article.
-
Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.Chem Phys Lipids. 2002 Dec 31;121(1-2):57-63. doi: 10.1016/s0009-3084(02)00146-9. Chem Phys Lipids. 2002. PMID: 12505690 Review.
-
Cannabinoids and pain.Curr Opin Investig Drugs. 2001 Mar;2(3):399-414. Curr Opin Investig Drugs. 2001. PMID: 11575713 Review.
Cited by
-
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29. Psychopharmacology (Berl). 2022. PMID: 35904579 Review.
-
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3364-78. doi: 10.1098/rstb.2011.0389. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23108553 Free PMC article. Review.
-
Potential role of cannabinoids in Parkinson's disease.Drugs Aging. 2000 Jun;16(6):391-5. doi: 10.2165/00002512-200016060-00001. Drugs Aging. 2000. PMID: 10939305 Review.
-
Neuroprotective strategies in Parkinson's disease : an update on progress.CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004. CNS Drugs. 2003. PMID: 12873156 Review.
-
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.Biochem J. 1997 Mar 1;322 ( Pt 2)(Pt 2):671-7. doi: 10.1042/bj3220671. Biochem J. 1997. PMID: 9065792 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources